Sudarshan Chemical Industries Ltd
SUDARSCHEMSudarshan Chemical Industries Ltd's price has outrun its earnings. −8.9% in a year against EPS −60.1% — the market is paying now for delivery later.
The sharpest disagreement: the price moved −8.9% in a year while annual EPS moved −60.1% — the difference is re-rating, and re-rating has to be repaid with earnings.
The price is in a confirmed uptrend (5 weeks in) while the P/E sits at the 98th percentile of its own 11-year range. Underneath, the last four quarters read improving — profit +87.3% year on year, and 133% of the last 3 years' profit arrived as cash. What settles it: whether earnings grow into a price that has already moved.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
Sudarshan Chemical Industries Ltd trades at ₹1,248, in a confirmed uptrend and 5 weeks into that stage. That is +21.7% against its own 200-day average. It sits at 98% of a 52-week range of ₹765 to ₹1,257. On relative strength it has been ahead of the NIFTY 500 on a trailing-13-week view for 9 straight weeks.
Today the stock is in a confirmed uptrend — week 5 of stage 2, confirmed. At ₹1,248 it trades +21.7% versus its 200-day average and sits at 98% of its 52-week range (₹765–₹1,257).
Against the market, two honest reads. Cumulative: over the last 10.5 years the stock moved +1,314% while the NIFTY 500 moved +267% — ahead of the index over the full window. Recent form: on a trailing-13-week view the stock has been ahead for 9 straight weeks — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Valuation P/E is the price of ₹1 of annual profit: how many rupees the market pays for each rupee the company earns in a year.
Sudarshan Chemical Industries Ltd trades at 97.8× P/E, about the priciest it has ever traded. Its long-run median P/E is 31.4×, measured across 10.5 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/E of 97.8× is about the priciest it has ever traded, against a long-run median of 31.4× measured over 10.5 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
🚨 Why the multiple sits where it does: over the past year annual EPS moved −60.1% against a −8.9% price move — the price outran earnings, pushing the multiple UP its own range.
The price move, decomposed: over 5y, of the +13.1%/yr price move, ~−9.9%/yr came from earnings growth and ~+23.0 pp from the multiple (expanding); over 10y, of the +13.5%/yr price move, ~+2.4%/yr came from earnings growth and ~+11.1 pp from the multiple (expanding). The split is the honest approximate (price return minus earnings growth); it makes the rally itself visible instead of hiding it behind the percentile.
Put together: the multiple is full against its own past, so the story rests on the earnings line underneath it, not the multiple.
Stage: Turning around Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
Sudarshan Chemical Industries Ltd reads as turning around on its fundamental arc. Turning around — profit growth swung from −64.6% at the trough to +2.3%, a 2-quarter improving streak, ROCE holding at 4.7%. The read is built from 12 quarters across 4 curves, on full evidence.
Why it matters: growth inflections are where re-ratings start — the curves say a turn is forming, so the question becomes whether the next quarters confirm it.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | +192.5% | +62.0% | +39.3% | +21.5% |
| Profit | −31.7% | −3.1% | −21.9% | −5.2% |
| EPS | −60.1% | −24.0% | −32.6% | −11.9% |
| Share price | −8.9% | +33.7% | +13.1% | +13.5% |
4-Factor Sector Score
43.4/100 — rank 7 of 10 in Dyes & Pigments · 94% evidence confidence
Sudarshan Chemical Industries Ltd scores 43.4 out of 100 against the 10 companies it is compared with in Dyes & Pigments, ranking 7. Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
The four contributions add to the total exactly: 19.8 + 7.8 + 6.9 + 8.9 = 43.4. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.
Revenue Revenue is the top line: everything the company billed its customers in the period.
Sudarshan Chemical Industries Ltd reported ₹2,642 Cr of revenue in the Jun 26 quarter, +5.4% year on year. That is the 12th straight quarter of year-on-year growth. Over 10 years it has compounded at 21.5% a year. The last full year, FY26, came in at ₹9,787 Cr. The last four reported quarters add to ₹9,922 Cr.
FY26 revenue came in at ₹9,787 Cr (+192.5% on the year), capping 10 years at 21.5% compound. The latest quarter (Jun 26) printed ₹2,642 Cr, +5.4% year on year — the 12th consecutive quarter of year-over-year growth.
Pace check: the last four quarters averaged +142.8% growth against the decade's 21.5% — the current year is running faster than its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew +90.1% over the last 4 quarters against +96.7%/yr over the last 8 — rolling over; TTM profit +2.3% vs −14.4%/yr — accelerating.
Operating margin Operating margin is what is left of every ₹100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.
Sudarshan Chemical Industries Ltd's operating margin is 10.0% in the Jun 26 quarter, +2.0 percentage points against the same quarter a year ago. Across 13 fiscal years the operating margin has ranged 6.0% to 16.0%. The current quarter sits inside that band.
The latest quarter's operating margin is 10.0%, +2.0 pp against the same quarter a year ago. Across 13 fiscal years the operating margin has ranged 6.0%–16.0%.
Why the margin moved: operating margin went +2.1 pp year on year while gross margin went +2.4 pp — the gain came mostly from the gross line: input costs and pricing.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
Sudarshan Chemical Industries Ltd earned ₹103 Cr of net profit in the Jun 26 quarter, +87.3% year on year. Full-year FY26 profit was ₹41.0 Cr. The 10-year compound rate is −5.2%. That is 3.9% of the quarter's revenue. The same quarter a year earlier earned ₹55.0 Cr. 1 of the last 12 reported quarters were loss-making.
Jun 26 profit was ₹103 Cr, +87.3% year on year. On the full year, FY26 printed ₹41.0 Cr (−31.7%), and the 10-year compound rate is −5.2%.
Why profit moved: revenue contributed +5.4% and the margin +2.0 pp — the quarter was margin-led: most of the profit growth came from keeping more of each sale.
Pace comparison, last four quarters: profit −3,883.1% vs revenue +142.8%. Profit is growing slower than sales — costs are eating the growth before it reaches the bottom line.
Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.
Over the last 3 fiscal years 133% of Sudarshan Chemical Industries Ltd's reported profit arrived as operating cash — the cash follows the profit. In FY26 that was ₹344 Cr of operating cash against ₹41.0 Cr of profit. After ₹583 Cr of capital spending, ₹−239 Cr was left as free cash.
FY26: operating cash of ₹344 Cr against reported profit of ₹41.0 Cr, leaving free cash of ₹−239 Cr after ₹583 Cr of capital spending. Across the last 3 fiscal years the conversion rate is 133% of profit.
Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.
Why conversion sits at 133%: the cash cycle stretched 44 days between FY21 and FY26 — more of each rupee of profit waits inside the cycle before arriving.
Router verdict: the bigger cash user is investment — capital spending ran 4.0× depreciation over three years, so the next section's job is to check what that build-out is buying.
Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).
Sudarshan Chemical Industries Ltd's cash conversion cycle runs 129 days in FY26, up from 85 days in FY21. Capital spending ran ₹2,615 Cr over the last 3 years. At FY26 sales of ₹9,787 Cr each day of that cycle holds about ₹26.8 Cr, so roughly ₹3,459 Cr sits inside the business at any moment.
FY26: debtors at 63 days, inventory at 179 days — roughly 5.9 months of stock waiting to sell; that is where the cash sits while it waits — for a full cycle of 129 days, looser than FY21's 85.
The full loop: cash goes out to suppliers and production on day 0; stock waits 179 days to sell; customers pay about 63 days after that; and suppliers themselves are paid at 113 days — netting out to the 129-day cycle.
In money terms: at FY26 sales of ₹9,787 Cr, each day of the cycle holds about ₹26.8 Cr — so the 129-day loop keeps roughly ₹3,459 Cr sitting inside the business at any moment.
On the investment side: capital spending of ₹2,615 Cr over the last 3 fiscal years against ₹654 Cr of depreciation — the company is building well ahead of wear-and-tear. Capital work-in-progress stands at ₹144 Cr (FY26) — capacity paid for but not yet earning.
The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.
Return on capital Return on capital employed (ROCE) is the profit the whole business earns on all the money in it — equity and debt together. It is the single best test of whether growth creates value or just size.
Sudarshan Chemical Industries Ltd earns a ROCE of 5% in FY26. Return on invested capital clears the cost of that capital by −10.2 percentage points, so growth here is not yet paying for the capital it uses. The wiring behind it is 0.4% net margin on 1.02× asset turns.
FY26 ROCE is 5%.
🚨 Why the return is what it is — the wiring (FY26): 0.4% net margin × 1.02× asset turns × 2.77× balance-sheet leverage ≈ 1.1% on equity. Margin does its share; leverage is a meaningful part of the equation.
The capstone test — ROIC − WACC: 1.8% − 12.0% = a −10.2 pp spread. The 12.0% is a standing assumption for the cost of capital in India, not a per-stock estimate — read the sign and the size of the spread, not the decimals. Negative — growth at these returns destroys value until the returns recover.
Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.
Sudarshan Chemical Industries Ltd carries total debt of ₹2,473 Cr against shareholder equity of ₹3,854 Cr as of Mar 26, a debt-to-equity of 0.64. On the annual view that ratio went from 0.99 in FY22 to 0.64 in FY26. Read the returns elsewhere on this page with that leverage in mind.
Mar 26: total debt of ₹2,473 Cr against shareholder equity of ₹3,854 Cr — a debt-to-equity of 0.64. On the annual view, debt-to-equity went from 0.99 (FY22) to 0.64 (FY26). Read the returns on this page with that leverage in mind.
Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.
Promoters cut 22.4 points of Sudarshan Chemical Industries Ltd over 8 quarters, the biggest move on the register. That takes promoters to 8.2% of the company. Domestic institutions moved +5.5 points over the same window, to 26.4%. The register is read on the four disclosed classes only; nothing is inferred between filings.
The register over the last two years — Promoters: −22.4 points over 8 quarters to 8.2%; Domestic institutions: +5.5 points over 8 quarters to 26.4%; Foreign institutions: +1.8 points over 8 quarters to 8.5%. Note the structure: promoters hold under 20% — this is a widely-held company where institutions, not a family, set the direction.
🚨 Why the register moved: promoters drove it (−22.4 points), absorbed on the other side by domestic institutions (+5.5 points) — distribution into the market’s bid.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
Sudarshan Chemical Industries Ltd: the Z-score is not available for this stock, so we say so rather than invent one. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure. The debt, cash-flow and return sections above carry the balance-sheet evidence this page does hold, and each of them states its own reporting date.
The safety line in one sentence: the Z-score is not available for this stock, so we say so rather than invent one.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1Bhageria Industries LtdBHAGERIA | 71.2/100Favorable setup87% evidence | LEADER | 30.2/35 Revenue 57% · PAT 55.8% · OPM change 4 pp 95% evidence | 14.4/25 ROCE 9.4% · OPM 15% 95% evidence | 9.0/20 P/E 20.1× · PEG — 50% evidence | 17.6/20 RS sector 26.3% · RS bench 70.5% · 1Y 59.4%12 of 12 weeks ahead 100% evidence |
| Exact sum: 30.2 + 14.4 + 9 + 17.6 = 71.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 2Ultramarine & Pigments LtdULTRAMAR | 66.2/100Favorable setup81% evidence | TURNING | 23.0/35 Revenue 15.6% · PAT 16.5% · OPM change 2 pp 95% evidence | 17.3/25 ROCE 10.8% · OPM 19% 95% evidence | 13.3/20 P/E 13.9× · PEG — 50% evidence | 12.6/20 RS sector 9.3% · RS bench 3.6% · 1Y -8.5%2 of 9 weeks ahead 70% evidence |
| Exact sum: 23 + 17.3 + 13.3 + 12.6 = 66.2 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence. | ||||||
| 3Atul LtdATUL | 62.3/100Mixed-positive evidence100% evidence | ASLEEP | 27.4/35 Revenue 15.8% · PAT 56.3% · OPM change 5 pp 100% evidence | 18.0/25 ROCE 14.9% · OPM 21% 100% evidence | 15.1/20 P/E 23.1× · PEG 0.69 100% evidence | 1.8/20 RS sector -27.2% · RS bench -0.4% · 1Y -0.9%0 of 12 weeks ahead 100% evidence |
| Exact sum: 27.4 + 18 + 15.1 + 1.8 = 62.3 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -27.2% and the one-year return is -0.9%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 4Bodal Chemicals LtdBODALCHEM | 58.8/100Mixed-positive evidence80% evidence | TURNING | 21.2/35 Revenue 27.6% · PAT 100% · OPM change 0 pp 95% evidence | 8.3/25 ROCE 5.6% · OPM 10% 95% evidence | 9.3/20 P/E 31.6× · PEG — 15% evidence | 20.0/20 RS sector 101.8% · RS bench 169.2% · 1Y 164.7%4 of 12 weeks ahead 100% evidence |
| Exact sum: 21.2 + 8.3 + 9.3 + 20 = 58.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 5Vidhi Specialty Food Ingredients LtdVIDHIING | 52.0/100Mixed-positive evidence81% evidence | BREAKING OUT | 14.7/35 Revenue 12.9% · PAT 10.4% · OPM change -5 pp 95% evidence | 17.8/25 ROCE 18.8% · OPM 18% 95% evidence | 10.7/20 P/E 31.4× · PEG — 50% evidence | 8.8/20 RS sector -9.9% · RS bench 5.3% · 1Y -13.3%5 of 10 weeks ahead 70% evidence |
| Exact sum: 14.7 + 17.8 + 10.7 + 8.8 = 52 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 6Kiri Industries LtdKIRIINDUS | 48.5/100Mixed-negative evidence75% evidence | BREAKING OUT | 22.4/35 Revenue 25% · PAT 100% · OPM change 13 pp 95% evidence | 5.3/25 ROCE -1.7% · OPM 5% 76% evidence | 11.5/20 P/E 4.4× · PEG — 15% evidence | 9.3/20 RS sector -15.7% · RS bench 15.1% · 1Y 2.7%4 of 12 weeks ahead 100% evidence |
| Exact sum: 22.4 + 5.3 + 11.5 + 9.3 = 48.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 7Sudarshan Chemical Industries Ltdthis pageSUDARSCHEM | 43.4/100Mixed-negative evidence94% evidence | BREAKING OUT | 19.8/35 Revenue 90.2% · PAT 2.3% · OPM change 2 pp 100% evidence | 7.8/25 ROCE 5.5% · OPM 10% 100% evidence | 6.9/20 P/E 97.8× · PEG 1.42 100% evidence | 8.9/20 RS sector -13.2% · RS bench 25.7% · 1Y -12.4%10 of 10 weeks ahead 70% evidence |
| Exact sum: 19.8 + 7.8 + 6.9 + 8.9 = 43.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 8Sudarshan Colorants India LtdSUDARCOLOR | 37.0/100Mixed-negative evidence87% evidence | BREAKING OUT | 6.8/35 Revenue -8.1% · PAT -25.4% · OPM change 0 pp 95% evidence | 14.5/25 ROCE 11.4% · OPM 12% 95% evidence | 14.1/20 P/E 16.9× · PEG — 50% evidence | 1.6/20 RS sector -30.7% · RS bench -5.6% · 1Y -36.3%6 of 12 weeks ahead 100% evidence |
| Exact sum: 6.8 + 14.5 + 14.1 + 1.6 = 37 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity. | ||||||
| 9Sadhana Nitro Chem LtdSADHNANIQ | 31.4/100Adverse evidence69% evidence | BREAKING OUT | 9.2/35 Revenue -69% · PAT -80% · OPM change 1.6 pp 71% evidence | 3.5/25 ROCE -11.1% · OPM 8.5% 95% evidence | 10.0/20 P/E — · PEG — 0% evidence | 8.7/20 RS sector -3.7% · RS bench 29.7% · 1Y 5.9%12 of 12 weeks ahead 100% evidence |
| Exact sum: 9.2 + 3.5 + 10 + 8.7 = 31.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 10Indokem LtdINDOKEM | 30.9/100Adverse evidence74% evidence | 6.8/35 Revenue -4.5% · PAT -57.5% · OPM change 0.5 pp 95% evidence | 2.5/25 ROCE 5.5% · OPM 4.8% 95% evidence | 8.5/20 P/E 764× · PEG — 15% evidence | 13.1/20 RS sector 27.1% · RS bench 0.7% · 1Y 27.4%6 of 12 weeks ahead 70% evidence | |
| Exact sum: 6.8 + 2.5 + 8.5 + 13.1 = 30.9 · Decision use: Price leads the evidence: RS versus the benchmark is 0.7%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is Sudarshan Chemical Industries Ltd's share price today?
Sudarshan Chemical Industries Ltd trades at ₹1,248, −8.9% over the past year. The company is valued at ₹9,938 Cr. The stock sits at 98% of its 52-week range of ₹765–₹1,257, +21.7% versus its 200-day average. On the tape, the price is in a confirmed uptrend, 5 weeks in. — as of 11 September 2026.
What were Sudarshan Chemical Industries Ltd's latest quarterly results?
Sudarshan Chemical Industries Ltd reported revenue of ₹2,642 Cr and net profit of ₹103 Cr for the Jun 26 quarter. Revenue rose 5.4% and profit rose 87.3% year on year. Earnings per share were ₹12.22. The operating margin was 10.0%, 2.0 pp higher than a year earlier. — as of 11 September 2026.
What is Sudarshan Chemical Industries Ltd's revenue?
Sudarshan Chemical Industries Ltd reported revenue of ₹2,642 Cr in the Jun 26 quarter, +5.4% year on year. For the full FY26 fiscal year, revenue was ₹9,787 Cr (+192.5%). Over the last 10 years revenue compounded at 21.5% a year. — as of 11 September 2026.
What is Sudarshan Chemical Industries Ltd's profit?
Sudarshan Chemical Industries Ltd earned ₹103 Cr of net profit in the Jun 26 quarter, +87.3% year on year. Full-year FY26 profit was ₹41.0 Cr. The operating margin ran 10.0% in the latest quarter. — as of 11 September 2026.
What is Sudarshan Chemical Industries Ltd's market cap?
Sudarshan Chemical Industries Ltd's market capitalisation is ₹9,938 Cr at a share price of ₹1,248. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 11 September 2026.
What is Sudarshan Chemical Industries Ltd's P/E ratio?
Sudarshan Chemical Industries Ltd trades at a P/E of 97.8×, at the 98th percentile of its own 11-year range, against a long-run median of 31.4×. This is a comparison with the stock's own history, not a value call — as of 11 September 2026.
Does Sudarshan Chemical Industries Ltd pay a dividend?
Yes — Sudarshan Chemical Industries Ltd's dividend payout was 176% of profit in FY26, and it recorded a payout in each of its last 13 reported fiscal years. This page holds the payout ratio, not a per-share amount. — as of 11 September 2026.
Is Sudarshan Chemical Industries Ltd overvalued?
On its own history, Sudarshan Chemical Industries Ltd looks expensive: its P/E of 97.8× sits at the 98th percentile of its 11-year range (long-run median 31.4×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 11 September 2026.
Is Sudarshan Chemical Industries Ltd growing?
Yes — Sudarshan Chemical Industries Ltd is growing: latest-quarter revenue +5.4% year on year, profit +87.3%, and the margin +2.0 pp at 10.0%. The 10-year compound rates are 21.5% (revenue) and −5.2% (profit). The earnings engine currently reads: improving — as of 11 September 2026.
How is Sudarshan Chemical Industries Ltd performing?
Sudarshan Chemical Industries Ltd is in a confirmed uptrend, 5 weeks in. Its latest quarter's revenue rose 5.4% and profit rose 87.3% year on year. Against the NIFTY 500 it has been ahead on a trailing-13-week view for 9 weeks. This describes what the data did, not a rating. — as of 11 September 2026.
What stage is Sudarshan Chemical Industries Ltd in?
Turning around — profit growth swung from −64.6% at the trough to +2.3%, a 2-quarter improving streak, ROCE holding at 4.7%. The read comes from the last 12 quarters of growth (revenue growth +90.1% latest, profit growth +2.3% latest, eps growth −8.4% latest) plus the ROCE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 11 September 2026.
Is Sudarshan Chemical Industries Ltd in an uptrend?
Yes — the price is in a confirmed uptrend (week 5 of stage 2), trading +21.7% versus its 200-day average and at 98% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 11 September 2026.
Is Sudarshan Chemical Industries Ltd beating the market?
On recent form, yes — Sudarshan Chemical Industries Ltd has been ahead of the NIFTY 500 on a trailing-13-week view for 9 straight weeks, the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.5 years the stock moved +1,314% against the NIFTY 500's +267% — ahead of the index over the full window. — as of 11 September 2026.
Will Sudarshan Chemical Industries Ltd's share price go up?
This page publishes no price forecast for Sudarshan Chemical Industries Ltd. What it measures instead: the share price is ₹1,248, the price is in a confirmed uptrend 5 weeks in. Its P/E of 97.8× sits at the 98th percentile of its own 11-year range. — as of 11 September 2026.
Who owns Sudarshan Chemical Industries Ltd?
Promoters hold 8.2% of Sudarshan Chemical Industries Ltd, foreign institutions 8.5%, domestic institutions 26.4% and the public 56.9% (latest quarter). The biggest move on the register over the last two years: Promoters cut 22.4 points over 8 quarters. — as of 11 September 2026.
Does Sudarshan Chemical Industries Ltd have too much debt?
It is moderate — Sudarshan Chemical Industries Ltd's debt-to-equity is 0.72, and operating profit covers the interest bill 4×. FY26 borrowings were ₹2,473 Cr against equity of ₹3,450 Cr. Read the returns on this page with that leverage in mind — as of 11 September 2026.
What is Sudarshan Chemical Industries Ltd's capex?
Sudarshan Chemical Industries Ltd spent ₹2,615 Cr on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY26 alone that was ₹583 Cr, with ₹144 Cr in capital work-in-progress — capacity paid for but not yet earning. — as of 11 September 2026.
What is Sudarshan Chemical Industries Ltd's cash flow?
Sudarshan Chemical Industries Ltd generated ₹344 Cr of operating cash flow in FY26 and ₹−239 Cr of free cash flow after ₹583 Cr of capital spending. Reported profit that year was ₹41.0 Cr, so operating cash ran ahead of profit. Cash-flow resolution for India is annual. — as of 11 September 2026.
Is Sudarshan Chemical Industries Ltd's profit real cash?
Yes — over the last 3 fiscal years, 133% of Sudarshan Chemical Industries Ltd's reported profit arrived as operating cash. In FY26, operating cash was ₹344 Cr against reported profit of ₹41.0 Cr. The cash then goes mostly into building capacity. Cash-flow resolution is annual — as of 11 September 2026.
Where is Sudarshan Chemical Industries Ltd in its business cycle?
Sudarshan Chemical Industries Ltd's FY26 operating margin was 6.0%, against a 13-year band of 6.0%–16.0%: the low end of its own band, which is where recoveries start when they come. The latest quarter ran 10.0%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 11 September 2026.
What could break the Sudarshan Chemical Industries Ltd story?
The sharpest disagreement: the price moved −8.9% in a year while annual EPS moved −60.1% — the difference is re-rating, and re-rating has to be repaid with earnings. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 11 September 2026.
Is Sudarshan Chemical Industries Ltd a stock worth studying right now?
This is not investment advice. The machine read: Sudarshan Chemical Industries Ltd's price has outrun its earnings. −8.9% in a year against EPS −60.1% — the market is paying now for delivery later. The sharpest open question: whether earnings grow into a price that has already moved. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 11 September 2026.
Not SEBI Registered !! Not Investment advice !!